The results showed that cyclin D1 protein expression was reduced after knockdown of DARS2 compared with expression in the negative control group (Fig. 5g), which indicated that DARS2 accelerated cell cycle progression in hepatoma cells. The gene discussed is CCND1; the disease is hepatocellular carcinoma.